<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04940793</url>
  </required_header>
  <id_info>
    <org_study_id>Ribeiro - POD FT</org_study_id>
    <nct_id>NCT04940793</nct_id>
  </id_info>
  <brief_title>Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens</brief_title>
  <acronym>RibeiroPODFT</acronym>
  <official_title>Visual and Refractive Outcomes of a New Diffractive Trifocal Toric Intraocular Lens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beaver-Visitec International, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beaver-Visitec International, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the visual performance and refractive&#xD;
      predictability with the diffractive toric Finevision POD FT IOL. Predicted and achieved&#xD;
      visual outcomes, visual performance at near, intermediate and far distance as well as photic&#xD;
      phenomena, rotational stability and spectacle independence will be investigated. The&#xD;
      follow-up period is 3 months after which vision and refraction should have stabilized.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This prospective study was performed to investigate the visual performance and refractive&#xD;
      predictability with the diffractive toric Finevision POD FT IOL (PhyslOL, Belgium). Predicted&#xD;
      and achieved visual outcomes, visual performance at near, intermediate and far distance as&#xD;
      well as rotational stability have been analyzed. The follow-up period was 6 months. All IOL&#xD;
      implantations were performed by the investigators Dr. Filomena Ribeiro and Dr. Tiago B&#xD;
      Ferreira (Hospital da Luz, Lisboa, Portugal). The study population consists of patients&#xD;
      undergoing routine cataract surgery. The study patients underwent binocular implantation of&#xD;
      Finevision IOLs depending on the preoperative amount of corneal astigmatism (either a toric&#xD;
      POD FT IOL in both eyes or a POD FT in the study eye and a non-toric POD F IOL in the&#xD;
      contralateral eye).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 18, 2017</start_date>
  <completion_date type="Actual">January 23, 2019</completion_date>
  <primary_completion_date type="Actual">January 23, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual performance</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Refractive predictability</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual performance : predicted and achieved</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL. Predicted and achieved visual outcomes will be investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual performance at near, intermediate and far distance</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the visual performance of the diffractive toric Finevision POD FT IOL. Visual performance at near, intermediate and far distance will be investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refractive predictability: photic phenomena</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The photic phenomena will be investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refractive predictability: rotational stability</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The rotational stability will be investigated.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Refractive predictability: spectacle independence</measure>
    <time_frame>3 Months</time_frame>
    <description>The purpose of this study is to investigate the refractive predictability of the diffractive toric Finevision POD FT IOL. The spectacle independence will be investigated.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">46</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients indicated for cataract surgery who are candidates for a trifocal IOL implantation and have corneal astigmatism over 1.00 D will be selected for inclusion by the investigators</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>POD FT</intervention_name>
    <description>Cataract surgery</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients indicated for cataract surgery who are candidates for a trifocal IOL implantation&#xD;
        and have corneal astigmatism over 1.00 D will be selected for inclusion by the&#xD;
        investigators. Only patients with binocular implantation of a Finevision IOL will be&#xD;
        included (either a POD FT in both eyes or a POD FT in the study eye and a POD F in the&#xD;
        contralateral eye).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 21 and older&#xD;
&#xD;
          -  bilateral implantation of a Finevision trifocal diffractive IOL (either a POD FT in&#xD;
             both eyes or a POD FT in the study eye and a POD F in the contralateral eye)&#xD;
&#xD;
          -  bilateral cataract surgery with grade 1-4 cataract&#xD;
&#xD;
          -  regular corneal astigmatism of 1.00 D or more before surgery in the study eye&#xD;
&#xD;
          -  previous written informed consent to surgery. Written informed consent to&#xD;
             participation in the study and data protection&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  relevant concomitant ophthalmic diseases (such as pseudoexfoliation, glaucoma,&#xD;
             traumatic cataract and other co-morbidity that could affect capsular bag stability&#xD;
             (e.g. Marfan syndrome)&#xD;
&#xD;
          -  irregular corneal astigmatism, any abnormality in corneal topography&#xD;
&#xD;
          -  systemic disease with impact on visual outcome&#xD;
&#xD;
          -  disability to understand and/or fill in patient questionnaires&#xD;
&#xD;
          -  history of other relevant previous ocular surgery (such as corneal surgery, glaucoma&#xD;
             surgery, vitreoretinal surgery) which might affect capsular stability or visual&#xD;
             outcomes&#xD;
&#xD;
          -  expected residual cylinder â‰¥ 0.50 D&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Filomena Ribeiro, MD, PhD, FEBO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital da Luz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital da Luz</name>
      <address>
        <city>Lisboa</city>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <results_reference>
    <citation>Visser N, Bauer NJ, Nuijts RM. Toric intraocular lenses: historical overview, patient selection, IOL calculation, surgical techniques, clinical outcomes, and complications. J Cataract Refract Surg. 2013 Apr;39(4):624-37. doi: 10.1016/j.jcrs.2013.02.020. Review.</citation>
    <PMID>23522584</PMID>
  </results_reference>
  <results_reference>
    <citation>de Vries NE, Nuijts RM. Multifocal intraocular lenses in cataract surgery: literature review of benefits and side effects. J Cataract Refract Surg. 2013 Feb;39(2):268-78. doi: 10.1016/j.jcrs.2012.12.002. Review.</citation>
    <PMID>23332253</PMID>
  </results_reference>
  <results_reference>
    <citation>Wolffsohn JS, Jinabhai AN, Kingsnorth A, Sheppard AL, Naroo SA, Shah S, Buckhurst P, Hall LA, Young G. Exploring the optimum step size for defocus curves. J Cataract Refract Surg. 2013 Jun;39(6):873-80. doi: 10.1016/j.jcrs.2013.01.031.</citation>
    <PMID>23688874</PMID>
  </results_reference>
  <results_reference>
    <citation>Vryghem JC, Heireman S. Visual performance after the implantation of a new trifocal intraocular lens. Clin Ophthalmol. 2013;7:1957-65. doi: 10.2147/OPTH.S44415. Epub 2013 Oct 1.</citation>
    <PMID>24124348</PMID>
  </results_reference>
  <results_reference>
    <citation>Sheppard AL, Shah S, Bhatt U, Bhogal G, Wolffsohn JS. Visual outcomes and subjective experience after bilateral implantation of a new diffractive trifocal intraocular lens. J Cataract Refract Surg. 2013 Mar;39(3):343-9. doi: 10.1016/j.jcrs.2012.09.017. Epub 2013 Jan 16.</citation>
    <PMID>23332118</PMID>
  </results_reference>
  <results_reference>
    <citation>Cochener B, Vryghem J, Rozot P, Lesieur G, Heireman S, Blanckaert JA, Van Acker E, Ghekiere S. Visual and refractive outcomes after implantation of a fully diffractive trifocal lens. Clin Ophthalmol. 2012;6:1421-7. doi: 10.2147/OPTH.S32343. Epub 2012 Sep 3.</citation>
    <PMID>22969289</PMID>
  </results_reference>
  <results_reference>
    <citation>Roensch MA, Charton JW, Blomquist PH, Aggarwal NK, McCulley JP. Resident experience with toric and multifocal intraocular lenses in a public county hospital system. J Cataract Refract Surg. 2012 May;38(5):793-8. doi: 10.1016/j.jcrs.2011.11.043. Epub 2012 Mar 15.</citation>
    <PMID>22425363</PMID>
  </results_reference>
  <results_reference>
    <citation>Visser N, Nuijts RM, de Vries NE, Bauer NJ. Visual outcomes and patient satisfaction after cataract surgery with toric multifocal intraocular lens implantation. J Cataract Refract Surg. 2011 Nov;37(11):2034-42. doi: 10.1016/j.jcrs.2011.05.041. Epub 2011 Sep 22.</citation>
    <PMID>21940140</PMID>
  </results_reference>
  <results_reference>
    <citation>Bellucci R, Bauer NJ, Daya SM, Visser N, Santin G, Cargnoni M, Nuijts RM; Lisa Toric Study Group. Visual acuity and refraction with a diffractive multifocal toric intraocular lens. J Cataract Refract Surg. 2013 Oct;39(10):1507-18. doi: 10.1016/j.jcrs.2013.04.036.</citation>
    <PMID>24075158</PMID>
  </results_reference>
  <results_reference>
    <citation>Alfonso JF, Knorz M, Fernandez-Vega L, RincÃ³n JL, Suarez E, Titke C, Kohnen T. Clinical outcomes after bilateral implantation of an apodized +3.0 D toric diffractive multifocal intraocular lens. J Cataract Refract Surg. 2014 Jan;40(1):51-9. doi: 10.1016/j.jcrs.2013.06.026.</citation>
    <PMID>24355720</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferreira TB, Marques EF, Rodrigues A, MontÃ©s-MicÃ³ R. Visual and optical outcomes of a diffractive multifocal toric intraocular lens. J Cataract Refract Surg. 2013 Jul;39(7):1029-35. doi: 10.1016/j.jcrs.2013.02.037. Epub 2013 May 13.</citation>
    <PMID>23680631</PMID>
  </results_reference>
  <results_reference>
    <citation>Knorz MC, RincÃ³n JL, Suarez E, Alfonso JF, FernÃ¡ndez-Vega L, Titke C, Kohnen T, Tucker S. Subjective outcomes after bilateral implantation of an apodized diffractive +3.0 D multifocal toric IOL in a prospective clinical study. J Refract Surg. 2013 Nov;29(11):762-7. doi: 10.3928/1081597X-20131021-06.</citation>
    <PMID>24203808</PMID>
  </results_reference>
  <results_reference>
    <citation>Chassain C, Pagnoulle C, Gobin L, Rozema J. [Evaluation of a new intraocular lens platform: centration and rotational stability]. J Fr Ophtalmol. 2013 Apr;36(4):336-42. doi: 10.1016/j.jfo.2012.04.012. Epub 2013 Jan 24. French.</citation>
    <PMID>23352708</PMID>
  </results_reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 18, 2021</study_first_submitted>
  <study_first_submitted_qc>June 23, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 28, 2021</study_first_posted>
  <last_update_submitted>June 23, 2021</last_update_submitted>
  <last_update_submitted_qc>June 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Trifocal</keyword>
  <keyword>Toric</keyword>
  <keyword>Hydrophilic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

